Echocardiographic changes and treatment goal rates after a 6-month combined treatment with amlodipine and losartan: a validation study in Andean countries (METAL study)

Carreño, Juan Guillermo Pérez; Romero, Juan Diego; Centeno, Juan Carlos Villar

doi:10.1177/1753944713506507

Cited by 1 publication

(2 citation statements)

References 22 publications

(21 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a study conducted by Pérez Carreńo et al [ 32 ] 99 patients with AH and HU received amlodipine at the dose of 5 mg and losartan at the dose of 50 mg or 100 mg according to their baseline BP. The secondary outcomes were changes in BP, serum UA and albuminuria from baseline.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

What is the role of angiotensin receptor blockers in treatment of hyperuricemia coexisting with arterial hypertension?

Nieradko-Iwanicka

2018

Reumatologia

View full text Add to dashboard Cite

Angiotensin receptor blockers or sartans are used to treat arterial hypertension. Hyperuricemia and arterial hypertension often coexist in patients with metabolic syndrome. Also hyperuricemia is correlated with an increased risk of cardiovascular disease and death. There are data suggesting that lowering serum urate may assist in control of arterial hypertension and use of certain drugs for arterial hypertension may reduce the serum uric acid level. The Polish Society of Arterial Hypertension recommends losartan for treatment of arterial hypertension in patients with coexisting hyperuricemia.The aim of the present review was to find evidence supporting the concept of use and explain the role of sartans in treatment of hyperuricemia.Thirty-five original and review articles about hyperuricemia and arterial hypertension focusing on the use of sartans in both these medical conditions were analyzed.In conclusion, sartans should be recommended for treatment of hyperuricemia coexisting with arterial hypertension in patients without bilateral renal artery stenosis and with exclusion of pregnant women.

show abstract

Section: Discussionmentioning

confidence: 99%

“…After 6 months there were 64 (95%) patients with adequately controlled AH. Every two of three patients reached adequate control of AH and HU after 6 months of combined antihypertensive treatment with amlodipine and losartan [ 32 ].…”

Section: Discussionmentioning

confidence: 99%

What is the role of angiotensin receptor blockers in treatment of hyperuricemia coexisting with arterial hypertension?

Nieradko-Iwanicka

2018

Reumatologia

View full text Add to dashboard Cite

show abstract

Echocardiographic changes and treatment goal rates after a 6-month combined treatment with amlodipine and losartan: a validation study in Andean countries (METAL study)

Abstract: Every two of three patients of this sample of Andean countries reached adequate control after 6 months of combined antihypertensive treatment with amlodipine/losartan.

Cited by 1 publication

References 22 publications

What is the role of angiotensin receptor blockers in treatment of hyperuricemia coexisting with arterial hypertension?

What is the role of angiotensin receptor blockers in treatment of hyperuricemia coexisting with arterial hypertension?

Contact Info

Product

Resources

About